Latest filing published 03 Jun 2020 for Genesis Healthcare, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by James H. Bloem span 6 companies, the busiest being Humana Inc, Allergan plc and Rotech Healthcare Inc. In total, 105 filings cover trades dated from 3 May 2006 to 3 June 2020.
Both buying and selling appear: 10 purchases worth €274k, against 18 sales worth €8.8M. No amount is published for 2 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 45 share grants and 29 option exercises.
Half of the purchases are above €13k and half below.
Most recently, on 3 June 2020, the filings show a share grant in Genesis Healthcare, Inc. The clock since the last published purchase (19 April 2010) now reads 6,031 days. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 100 declarations